SARS-CoV-2 seroprevalence among parturient women in Philadelphia

See allHide authors and affiliations

Science Immunology  29 Jul 2020:
Vol. 5, Issue 49, eabd5709
DOI: 10.1126/sciimmunol.abd5709

Monitoring SARS-CoV-2 exposure

When the SARS-CoV-2 pandemic started, stay-at-home orders led to postponement of routine medical appointments, making it difficult to perform community-level seroprevalence studies. Pregnant women, particularly those near their delivery dates, continued to have regular interactions with their medical care providers. Flannery et al. measured the exposure rate of SARS-CoV-2 in parturient women in Philadelphia who came to the hospital to deliver between 4 April and 3 June 2020. Using IgG and IgM antibody tests, they evaluated exposure of 1293 parturient women to SARS-CoV-2 and found that 6.2% of these women had evidence of exposure to the virus. They found considerable racial differences in exposure rates, with higher rates of seropositivity in Black/non-Hispanic and Hispanic/Latino women as compared with Asian and White/non-Hispanic women.


Limited data are available for pregnant women affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Serological tests are critically important for determining SARS-CoV-2 exposures within both individuals and populations. We validated a SARS-CoV-2 spike receptor binding domain serological test using 834 pre-pandemic samples and 31 samples from COVID-19–recovered donors. We then completed SARS-CoV-2 serological testing of 1293 parturient women at two centers in Philadelphia from 4 April to 3 June 2020. We found 80 of 1293 (6.2%) of parturient women had immunoglobulin G (IgG) and/or IgM SARS-CoV-2–specific antibodies. We found race/ethnicity differences in seroprevalence rates, with higher rates in Black/non-Hispanic and Hispanic/Latino women. Of the 72 seropositive women who also received nasopharyngeal polymerase chain reaction testing during pregnancy, 46 (64%) were positive. Continued serologic surveillance among pregnant women may inform perinatal clinical practices and can potentially be used to estimate exposure to SARS-CoV-2 within the community.

This is an open-access article distributed under the terms of the Creative Commons Attribution license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

View Full Text

Stay Connected to Science Immunology